Cell Density-Dependent Proliferative Effects of Transforming Growth Factor (TGF)-β1, β2, and β3 in Human Chondrosarcoma Cells HCS-2/8 Are Associated with Changes in the Expression of TGF-β Receptor Type I

REFERENCES

• Dorfman H. D., Czerniak B. Malignant Cartilage Tumors. Bone Tumors. Mosby, St. Louis 1998; 353–440
   Google Scholar
• Unni K. K. Chondrosarcoma (Primary, Secondary, Dedifferentiated, and Clear-Cell). Dahlin's Bone Tumors. 5th Ed., Lippincott-Raven, Philadelphia 1996; 71–108
   Google Scholar
• Evans H. L., Ayala A. G., Romsdahl M. M. Prognostic Factors in Chondrosarcoma of Bone. Cancer 1977; 40: 818–831
   PubMed Web of Science ®Google Scholar
• Takigawa M., Tajima K., Pan Ho H., Enomoto M., Kinoshita A., Suzuki F., Takano Y., Mori Y. Establishment of a Clonal Human Chondrosarcoma Cell Line with Cartilage Phenotypes. Cancer Res. 1989; 49: 3996–4002
   PubMed Web of Science ®Google Scholar
• Takigawa M., Okawa T., Pan Ho H., Aoki C., Takahashi K., Zue J., Suzuki F., Kinoshita A. Insulin-LikeGrowth Factors I and II Are Autocrine Factors in Stimulating Proteoglycan Synthesis, a Marker of Differentiated Chondrocytes, Acting Through Their Respective Receptors on a Clonal Human Chondrosarcoma-Derived Chondrocyte Cell Line, HCS-2/8. Endocrinology 1997; 138: 4390–4400
   PubMed Web of Science ®Google Scholar
• Tuckwell D. S., Ayad S., Grant M. E., Takigawa M., Humphries M. J. Conformation Dependence of Integrin- Type II Collagen Binding. Inability of Collagen Peptides to Support α2b1 Binding, and Mediation of Adhesion to Denaturated Collagen by a Novel α5b1-Fibronectin Bridge. J. Cell Sci. 1994; 107: 993–1005
   PubMed Web of Science ®Google Scholar
• Enomoto M., Takigawa M. Regulation of Tumor Derived and Immortalized Chondrocytes. Biological Regulation of the Chondrocytes, M. Adolphe. CRC Press, Boca Raton 1992; 21–338
   Google Scholar
• Roberts A. B., Sporn M. B. Peptide Growth Factors and Their Receptors, Part I, M. B. Sporn, A. B. Roberts. Springer-Verlag, Berlin 1991; 419–472
   Google Scholar
• Boume`diene K., Felisaz N., Pujol J-P. Cell Cycle Dependent Expression of Transforming Growth Factor β Type I Receptor Correlates with Differential Proliferative Effects of TGF-β1 in Articular Chondrocytes. Exp. Cell Res. 1998; 243: 173–184
   PubMed Web of Science ®Google Scholar
• Rosier R. N., O'keefe R. J., Grabb I. D., et al. Transforming Growth Factor Beta: An Autocrine Regulator of Chondrocytes. Connect. Tissue Res. 1989; 20: 295–301
   PubMed Web of Science ®Google Scholar
• Sigel A. V., Centrella M., Eghbali-Webb M. Regulation of Proliferative Response of Cardiac Fibroblasts by Transforming Growth Factor Beta 1. J. Mol. Cell. Cardiol. 1996; 28: 1921–1929
   PubMed Web of Science ®Google Scholar
• Sporn M. B., Roberts A. B. The Transforming Growth Factor-Betas: Past, Present, and Future. Ann. N.Y. Acad. Sci. 1990; 593: 1–6
   PubMed Web of Science ®Google Scholar
• Nathan C., Sporn M. Cytokines in Context. J. Cell Biol. 1991; 113: 981–986
   PubMed Web of Science ®Google Scholar
• Moses H. L., Yang E. Y., Pietenpol J. A. TGF-β Stimulation and Inhibition of Cell Proliferation: New Mechanistic Insights. Cell 1990; 63: 245–247
   PubMed Web of Science ®Google Scholar
• Wrana J. L., Attisano L., Carcamo J., Zentella A., Doody J., Laiho M., Wang X. F., Massague J. TGF-βSignals Through a Heteromeric Protein Kinase Receptor Complex. Cell 1992; 71: 1003–1014
   PubMed Web of Science ®Google Scholar
• Wrana J. L., Attisano L., Wieser R., Ventura F., Massague J. Mechanism of Activation of the TGF-β Receptor. Nature 1994; 370: 341–347
   PubMed Web of Science ®Google Scholar
• ten Dijke P., Miyazono K., Heldin C. H. Signaling via Hetero-Oligomeric Complex of Type I and Type II Serine/Threonine Kinase Receptors. Curr. Opin. Cell Biol. 1996; 8: 139–145
   PubMed Web of Science ®Google Scholar
• Macias-Silva M., Abdollah S., Hoodless P. A., Pirone R., Attisano L., Wrana J. L. MADR2 Is a Substrate of the TGF-β Receptor and Its Phosphorylation Is Required for Nuclear Accumulation and Signalling. Cell 1996; 87: 1215–1224
   PubMed Web of Science ®Google Scholar
• Zhang Y., Feng X. H., Wu R. Y., Derynck R. Receptor-Associated Mad Homologues Synergize as Effectors of the TGF-β Response. Nature 1996; 383: 168–172
   PubMed Web of Science ®Google Scholar
• Nakao A., Imamura T., Souchelnytskyi S., Kawabata M., Ishisaki A., Oeda E. TGF-β Receptor-Mediated Signalling Through Smad2, Smad3 and Smad4. EMBO J. 1997; 6: 5353–5362
   Google Scholar
• Zhang Y., Musci T., Derynck R. The Tumor Suppressor Smad4/DPC P4 as a Central Mediator of Smad Function. Curr. Biol. 1997; 7: 270–276
   PubMed Web of Science ®Google Scholar
• Alexandrow M. G., Moses H. L. Transforming Growth Factor β and Cell Cycle Regulation. Cancer Res. 1995; 55: 1452–1457
   PubMed Web of Science ®Google Scholar
• Hannon G. J., Beach D. p15INK4B Is a Potential Effector of TGF-β-Induced Cell Cycle Arrest. Nature 1994; 371: 257–261
   PubMed Web of Science ®Google Scholar
• Datto M. B., Li Y., Panus J. F., Howe D. J., Xiong Y., Wang X. F. Transforming Growth Factor β Induces the Cyclin-Dependent Kinase Inhibitor P21 Through a p53- Independent Mechanism. Proc. Natl. Acad. Sci. U.S.A. 1995; 92: 5545–5549
   PubMed Web of Science ®Google Scholar
• Li C. Y., Suardet L., Little J. B. Potential Role of WAF1/Cip1/p21 as a Mediator of TGF-β Cytoinhibitory Effect. J. Biol. Chem. 1995; 270: 4971–4974
   PubMed Web of Science ®Google Scholar
• Ewen M. E., Sluss H. K., Whitehouse L. L., Livingston D. M. TGF-β Inhibition of Cdk4 Synthesis Is Linked to Cell Cycle Arrest. Cell 1993; 74: 1009–1020
   PubMed Web of Science ®Google Scholar
• Toyoshima H., Hunter T. p27, a Novel Inhibitor of G1 Cyclin-Cdk Protein Kinase Activity Is Related to p21. Cell 1994; 78: 67–74
   PubMed Web of Science ®Google Scholar
• Glick A. B., Lee M. M., Darwiche N., Kulkarni A. B., Karlsson S., Yuspa S. H. Targeted Deletion of the TGF- β1 Gene Causes Rapid Progression to Squamous Cell Carcinoma. Gene Dev. 1994; 8: 2429–2440
   PubMed Web of Science ®Google Scholar
• Glick A. B., Lee M. M., Wu I. H., et al. Genomic Instability in Cell Lines Derived from TGF-β1 Null Keratinocytes. Proc. 86th Ann. Meeting Am. Assoc. Cancer Res. 1995; 36: 544
   Google Scholar
• Markowitz S., Wang J., Myeroff L., Parsons R., Sun L., Lutterbaugh J., Fan R. S., Zborowska E., Kinzler K. W., Vogelstein B. Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability. Science 1995; 268: 1336–1338
   PubMed Web of Science ®Google Scholar
• Park K., Kim S. J., Bang Y. J., Park J. G., Kim N. K., Roberts A. B., Sporn M. B. Genetic Changes in the Transforming Growth Factor β (TGF-β) Type II Receptor Gene in Human Gastric Cancer Cells: Correlation with Sensitivity to Growth Inhibition by TGF-β. Proc. Natl. Acad. Sci. U.S.A. 1994; 91: 8772–8776
   PubMed Web of Science ®Google Scholar
• Glick A. B., Kulkarni A. B., Tennenbaum T., Hennings H., Flanders K. C., O'Reilly M., Sporn M. B., Karlsson S., Yuspa S. H. Loss of Expression of Transforming Growth Factor β in Skin and Skin Tumors is Associated with Hyperproliferation and a High Risk for Malignant Conversion. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 6076–6080
   PubMed Web of Science ®Google Scholar
• Lawrence D. A. Transforming Growth Factor-β: An Overview. Kidney Int. 1995; 47((suppl 49))519–523
   Google Scholar
• Leof E. B., Proper J. A., Goustin A. S., Shipley G. D., DiCorleto P. E., Moses H. L. Induction of c-sis mRNA and Activity Similar to Platelet-Derived Growth Factor by Transforming Growth Factor β: A Proposed Model for Indirect Mitogenesis Involving Autocrine Activity. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 2453–2457
   PubMed Web of Science ®Google Scholar
• Kim T. A., Ravitz M. J., Wenner C. E. Transforming Growth Factor-Beta Regulation of Retinoblastoma Gene Product and E2F Transcription Factor During Cell Cycle Progression in Mouse Fibroblasts. J. Cell Physiol. 1994; 160: 1–9
   PubMed Web of Science ®Google Scholar
• Ravitz M. J., Yan S., Herr K. D., Wenner C. E. Transforming Growth Factor Beta-Induced Activation of Cyclin E-cdk 2 Kinase and Down-Regulation of p27 Kip1 in C3H 10T1/2 Mouse Fibroblasts. Cancer Res. 1995; 55: 1413–1416
   PubMed Web of Science ®Google Scholar
• Machwate M., Julienne A., Moukhtar M., Lomri A., Marie P. J. c-fos Protooncogene Is Involved in the Mitogenic Effect of Transforming Growth Factor-Beta in Osteoblastic Cells. Mol. Endocrinol 1995; 9: 187–198
   PubMed Web of Science ®Google Scholar
• Raynal S., Lawrence D. A. Differential Effects of Transforming Growth Factor-β1 on Protein Levels of p21 WAF and cdk-2 and on cdk-2 Kinase Activity in Human RD and CCL64 Mink Lung Cells. Int. J. Oncol. 1995; 7: 337–341
   PubMed Web of Science ®Google Scholar
• Dkhissi F., Raynal S., Jullien P., Lawrence D. A. Growth Stimulation of Murine Fibroblasts by TGF-β1 Depends on the Expression of a Bifunctional p53 Protein. Oncogene 1999; 18: 703–11
   PubMed Web of Science ®Google Scholar
• Fynan T. M., Reis M. Resistance to Inhibition of Cell Growth by Transforming Growth Factor-β and Its Role in Oncogenesis. Crit. Rev. Oncog. 1993; 4: 493–540
   PubMed Web of Science ®Google Scholar
• Reiss M. Transforming Growth Factor-β and Cancer: A Love-Hate Relationship. Oncol. Res. 1997; 9: 447–457
   PubMed Web of Science ®Google Scholar
• Redini F., Galera P., Mauviel A., Loyau G., Pujol J. P. Transforming Growth Factor β Stimulates Collagen and Glycosaminoglycan Biosynthesis in Cultured Rabbit Articular Chondrocytes. FEBS Lett. 1988; 234: 172–176
   PubMed Web of Science ®Google Scholar
• Morales T. I. Transforming Growth Factor-β1 Stimulates Synthesis of Proteoglycan Aggregates in Calf Articular Cartilage Organ Cultures. Arch. Biochem. Biophys. 1991; 286: 99–106
   PubMed Web of Science ®Google Scholar
• Beuningen H. M., Van Der Kraan P. M., Arntz O. J., Loyau G., Pujol J. P. Transforming Growth Factor-β Stimulates Articular Chondrocyte Proteoglycan Synthesis and Induces Osteophyte Formation in the Murine Knee Joint. Lab. Invest. 1994; 71: 279–290
   PubMed Web of Science ®Google Scholar
• Serra R., Johnson M., Filvaroff LaBorde J., Sheehan D. M., Derynck R., Moses H. L. Expression of a Truncated, Kinase-Defective TGF-β Type II Receptor in Mouse Skeletal Tissue Promotes Terminal Chondrocyte Differentiation and Osteoarthritis. J. Cell Biol. 1997; 139: 541–552
   PubMed Web of Science ®Google Scholar
• Benya P. D., Schaeffer J. D. Dedifferentiated Chondrocytes Reexpress the Differentiated Collagen Phenotype When Cultured in Agarose Gels. Cell 1982; 30: 215–224
   PubMed Web of Science ®Google Scholar
• Luparello C., Ginty A. F., Gallagher J. A., Pucci-Minafra I., Minafra S. Transforming Growth Factor-β1, β2 and β3, Urokinase and Parothyroid Hormone Related Peptide Expression in 8701-BC Breast Cancer Cells and Clones. Differentiation 1993; 55: 73–80
   PubMed Web of Science ®Google Scholar
• Franzen P., ten Dijke P., Tchijo H., Yamashita H., Schulz P., Heldin C. H., Miyazono K. Cloning of TGF- β Type I Receptor that Forms a Heteromeric Complex with the TGF-β Type II Receptor. Cell 1993; 75: 681–692
   PubMed Web of Science ®Google Scholar
• Lin H. V., Wang X. F., Ng-Eaton E., Weinberg R. A., Lodish H. F. Expression Cloning of the Type II Receptor, a Functionnal Transmembrane Serine/Threonine Kinase. Cell 1992; 68: 775–785
   PubMed Web of Science ®Google Scholar
• Sporn M. B., Roberts A. B. Autocrine Growth Factors and Cancer. Nature 1985; 313: 745–747
   PubMed Web of Science ®Google Scholar
• Bajzer Z., Vuk-Pavlovìc S. Quantitative Aspect of Autocrine Regulation in Tumors. Crit. Rev. Oncog 1990; 2: 53–73
   PubMedGoogle Scholar
• Eithier S. P. Growth Factor Synthesis and Human Breast Cancer Progression. J. Natl. Cancer Inst. 1995; 87: 964–973
   PubMed Web of Science ®Google Scholar
• Guerne P. A., Lotz M. Interleukin-6 and Transforming Growth Factor-β Synergistically Stimulate Chondrosarcoma Cell Proliferation. J. Cell Physiol. 1991; 149: 117–124
   PubMed Web of Science ®Google Scholar
• Vivien D., Galera P., Lebrun E., Loyau G., Pujol J. P. Differential Effect of Transforming Growth Factor β and Epidermal Growth Factor on the Cell Cycle of Cultured Rabbit Articular Chondrocytes. J. Cell Physiol. 1990; 143: 534–546
   PubMed Web of Science ®Google Scholar
• Vivien D., Galera P., Lebrun E., Daireaux M., Loyau G., Pujol J. P. TGF-β-Induced G2/M Delay in Proliferating Rabbit Articular Chondrocytes Is Associated with an Enhancement of Replication Rate and a cAMP Decrease: Possible Involvement of Pertussis Toxin-Sensitive Pathway. J. Cell Physiol 1992; 150: 291–298
   PubMed Web of Science ®Google Scholar
• Markowitz S., Roberts A. B. Tumor Suppressor Activity of the TGF-β Pathway in Human Cancers. Cytokine Growth Factor Rev. 1996; 7: 93–102
   PubMedGoogle Scholar
• Kim I. Y., Ahn H. J., Zelner D. J., Shaw J. W., Sensibar J. A., Kim J. H., Kato M., Lee C. Genetic Change in Transforming Growth Factor β (TGF-β) Receptor Type I Gene Correlates with Insensitivity to TGF-β1 in Human Prostate Cancer Cells. Cancer Res. 1996; 56: 44–48
   PubMed Web of Science ®Google Scholar
• Wang J., Han W., Zborowska E., Liang J., Wang X., Willson J. K., Sun L., Brattain M. G. Reduced Expression of Transforming Growth Factor β Type I Receptor Contributes to the Malignancy of Human Colon Carcinoma Cells. J. Biol. Chem. 1996; 271: 17366–17371
   PubMed Web of Science ®Google Scholar
• Tsukazaki T., Chiang T. A., Davison A. F., Attisano L., Wrana J. L. SARA, a FYVE Domain Protein that Recruits Smad2 to the TGF Beta Receptor. Cell 1998; 95: 779–91
   PubMed Web of Science ®Google Scholar
• Choy L., Derynck R. The Type II Transforming Growth Factor (TGF)-β Receptor-Interacting Protein TRIP-1 Acts as a Modulator of the TGF-β Response. J. Biol. Chem. 1998; 273: 31455–31462
   PubMed Web of Science ®Google Scholar
• Bascom C., Walfshohl J. R., Caffrey R. J., Madisen L., Webb N. R., Purchio A. R., Derynck R., Moses H. L. Complex Regulation of Transforming Growth Factor-β1, β2 and β3 mRNA Expression in Mouse Fibroblasts and Keratinocytes, by Transforming Growth Factor β1 and β2. Mol. Cell Biol. 1989; 9: 5508–5515
   PubMed Web of Science ®Google Scholar
• Lawrence D. A., Pircher R., Krycevic-Martinerie C., Jullien P. Normal Embryo Fibroblasts Release Transforming Growth Factors in a Latent Form. J. Cell Physiol 1984; 121: 184–188
   PubMed Web of Science ®Google Scholar
• Antonelli-Orlidge A., Saunders K. B., Smith S. R., D'Amore P. A. An Activated Form of Transforming Growth Factor Beta Is Produced by Cocultures of Endothelial Cells and Pericytes. Proc. Natl. Acad. Sci. 1989; 86: 4544–4548
   PubMed Web of Science ®Google Scholar
• Sato Y., Rifkin D. B. Inhibition of Endothelial Cell Movement by Pericytes and Smooth Muscle Cells: Activation of a Latent Transforming Growth Factor-Beta 1- Like Molecule by Plasmine During Co-culture. J. Cell Biol 1989; 109: 309–315
   PubMed Web of Science ®Google Scholar
• Kondaiah P., Sands M. J., Smith J. M., Fields A., Roberts A. B., Sporn M. B., Melton D. A. Identification of a Novel Transforming Growth Factor-β (TGF-β5) mRNA in Xenopus laevis. J. Biol. Chem. 1990; 265: 1089–1093
   PubMed Web of Science ®Google Scholar
• O'Connor-McCourt M. D., Wakefield L. M. Latent Transforming Growth Factor-Beta in Serum. A Specific Complex with Alpha-2-Macroglobulin. J. Biol. Chem. 1987; 262: 14090–14099
   PubMed Web of Science ®Google Scholar
• Schultz-Cherry S., Murphy-Ullrich J. E. Thrombospondin Causes Activation of Latent Transforming Growth Factor-Beta Secreted by Endothelial Cells by a Novel Mechanism. J. Cell Biol. 1993; 122: 923–932
   PubMed Web of Science ®Google Scholar
• Jullien P., Berg T. M., Lawrence D. A. Acidic Cellular Environments: Activation of latent TGF-Beta and Sensitization of Cellular Responses to TGF-Beta and EGF. Int. J. Cancer 1989; 43: 886–891
   PubMed Web of Science ®Google Scholar